Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

You-Ping Liu

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Oral Oncology|February 20, 2021
Metastatic characteristics associated with survival of synchronous metastatic nasopharyngeal carcinoma in non-epidemic areasMei Lin, Qi Yang, Rui You, et al.
Oral Oncology|January 9, 2025
Postradiotherapy nasopharyngeal necrosis with granulation mass: Insights from a multicentre studyZheng-Kai Feng, Wen-Bin Wu, Rui-Chao Zou, et al.
BMC Cancer|May 10, 2024
Outcomes of patients in nasopharyngeal adenoid cystic carcinoma in the IMRT era: a single-center experienceWen-Bin Wu, Wu-Lin Cai, Ye-Hao Zou, et al.
Theranostics|December 1, 2017
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-AnalysisRui You, Ying-Shu Cao, Pei-Yu Huang, et al.
JAMA Network Open|July 27, 2023
Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical TrialQi Yang, Xiong Zou, Yu-Long Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
A Prognostic Bio-Model Based on SQSTM1 and N-Stage Identifies Nasopharyngeal Carcinoma Patients at High Risk of Metastasis for Additional Induction ChemotherapyQi Yang, Meng-Xia Zhang, Xiong Zou, et al.
Oral Oncology|August 23, 2021
The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trialQi Yang, Le Xia, Mei Lin, et al.
Head & Neck|November 17, 2023
A novel endoscopic nasopharyngectomy by low-temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinomaXiong Zou, Zheng-Kai Feng, Yi-Jun Hua, et al.
Med (New York, N.Y.)|October 9, 2025
TQB2450 plus intensity-modulated radiotherapy in recurrent nasopharyngeal carcinoma: An open-label, single-arm, phase II trialTian-Liang Xia, Wenxuan Huang, You-Ping Liu, et al.
The Lancet. Oncology|February 18, 2021
Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trialYou-Ping Liu, Yi-Hui Wen, Jun Tang, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Oral Oncology|February 20, 2021
Metastatic characteristics associated with survival of synchronous metastatic nasopharyngeal carcinoma in non-epidemic areasMei Lin, Qi Yang, Rui You, et al.
Oral Oncology|January 9, 2025
Postradiotherapy nasopharyngeal necrosis with granulation mass: Insights from a multicentre studyZheng-Kai Feng, Wen-Bin Wu, Rui-Chao Zou, et al.
BMC Cancer|May 10, 2024
Outcomes of patients in nasopharyngeal adenoid cystic carcinoma in the IMRT era: a single-center experienceWen-Bin Wu, Wu-Lin Cai, Ye-Hao Zou, et al.
Theranostics|December 1, 2017
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-AnalysisRui You, Ying-Shu Cao, Pei-Yu Huang, et al.
JAMA Network Open|July 27, 2023
Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical TrialQi Yang, Xiong Zou, Yu-Long Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
A Prognostic Bio-Model Based on SQSTM1 and N-Stage Identifies Nasopharyngeal Carcinoma Patients at High Risk of Metastasis for Additional Induction ChemotherapyQi Yang, Meng-Xia Zhang, Xiong Zou, et al.
Oral Oncology|August 23, 2021
The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trialQi Yang, Le Xia, Mei Lin, et al.
Head & Neck|November 17, 2023
A novel endoscopic nasopharyngectomy by low-temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinomaXiong Zou, Zheng-Kai Feng, Yi-Jun Hua, et al.
Med (New York, N.Y.)|October 9, 2025
TQB2450 plus intensity-modulated radiotherapy in recurrent nasopharyngeal carcinoma: An open-label, single-arm, phase II trialTian-Liang Xia, Wenxuan Huang, You-Ping Liu, et al.
The Lancet. Oncology|February 18, 2021
Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trialYou-Ping Liu, Yi-Hui Wen, Jun Tang, et al.
Pageof 9